| Literature DB >> 30312023 |
Cheng Zhang1, Ping Wang2, Yongqiang Li1, Changxin Huang1, Wei Ni1, Yidan Chen1, Junping Shi1, Gongying Chen1, Xiangrong Hu1, Meng Ye2, Shiwei Duan2, Kaifeng Wang1.
Abstract
Hepatocellular carcinoma (HCC) is a prevalent liver malignancy that can be developed from nonalcoholic fatty liver disease (NAFLD). Numerous pathophysiological alterations, including insulin resistance, specific cytokine release, oxidative stress, and mitochondrial damage, are involved in the transition of NAFLD to cirrhosis and HCC. MicroRNAs, as post-transcriptional modulators, play a critical role in the pathogenesis of NAFLD-related HCC by regulating lipid metabolism, glucose homeostasis, cell proliferation, apoptosis, migration, and differentiation. This review summarizes the current progress of microRNAs in the risk and prognosis of NAFLD-related HCC. Anat Rec, 302:193-200, 2019.Entities:
Keywords: hepatocellular carcinoma; microRNA; nonalcoholic fatty liver disease; therapy
Mesh:
Substances:
Year: 2018 PMID: 30312023 DOI: 10.1002/ar.23954
Source DB: PubMed Journal: Anat Rec (Hoboken) ISSN: 1932-8486 Impact factor: 2.064